IRIC’s assets, providing undeniable value

The Institute has a unique model that combines, under one roof: 29 teams of scientists, a research valorization team, 10 core facilities and a Drug Discovery Unit. The synergy between all of these components is what creates its value.

Unique, its model has been the key to success for almost 20 years; it has led to several major discoveries that are now benefiting cancer patients.

IRIC is a research hub and training centre where cutting-edge fundamental research is carried out using specialized infrastructures. It’s where discoveries are transformed into clinical applications for treating cancer.

The specific role of IRIC’s Drug Discovery Unit is to design and synthesize new chemical entities possessing biological or therapeutic activity against cancer.

IRICoR is a valorization cluster that bridges the gap between academia and the biopharmaceutical sector. It accelerates the transformation of drug discovery projects into new therapies.